1492 related articles for article (PubMed ID: 18343174)
1. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
Shinnar S; Pellock JM; Conry JA
Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
Wroe SJ; Yeates AB; Marshall A
Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
[TBL] [Abstract][Full Text] [Related]
4. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy.
Lee YJ; Kang HC; Seo JH; Lee JS; Kim HD
Brain Dev; 2010 Mar; 32(3):208-12. PubMed ID: 19304420
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
7. Zonisamide as adjunctive therapy for refractory partial seizures.
Brodie MJ
Epilepsy Res; 2006 Feb; 68 Suppl 2():S11-6. PubMed ID: 16316744
[TBL] [Abstract][Full Text] [Related]
8. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
Baulac M; Leppik IE
Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
[TBL] [Abstract][Full Text] [Related]
10. Zonisamide in the management of epilepsy--Japanese experience.
Ohtahara S
Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
[TBL] [Abstract][Full Text] [Related]
11. Long-term use of zonisamide in refractory childhood-onset epilepsy.
Kluger G; Zsoter A; Holthausen H
Eur J Paediatr Neurol; 2008 Jan; 12(1):19-23. PubMed ID: 17574461
[TBL] [Abstract][Full Text] [Related]
12. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures.
Sackellares JC; Ramsay RE; Wilder BJ; Browne TR; Shellenberger MK
Epilepsia; 2004 Jun; 45(6):610-7. PubMed ID: 15144425
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy.
Kothare SV; Kaleyias J; Mostofi N; Valencia I; Melvin JJ; Hobdell E; Khurana DS; Legido A
Pediatr Neurol; 2006 May; 34(5):351-4. PubMed ID: 16647993
[TBL] [Abstract][Full Text] [Related]
14. Practical prescribing and long-term efficacy and safety of zonisamide.
Leppik IE
Epilepsy Res; 2006 Feb; 68 Suppl 2():S17-24. PubMed ID: 16406743
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
[TBL] [Abstract][Full Text] [Related]
16. Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: a multicenter open-label single-arm trial in Korean patients.
Heo K; Lee BI; Yi SD; Cho YW; Shin DJ; Song HK; Kim OJ; Park SP; Kim SE; Kim SH; Lee JH; Kim KS; Lee SJ
Seizure; 2012 Apr; 21(3):188-93. PubMed ID: 22226572
[TBL] [Abstract][Full Text] [Related]
17. Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.
Coppola G; Grosso S; Verrotti A; Parisi P; Luchetti A; Franzoni E; Mangano S; Pelliccia A; Operto FF; Iannetti P; Curatolo P; Balestri P; Pascotto A
Epilepsy Res; 2009 Feb; 83(2-3):112-6. PubMed ID: 19081227
[TBL] [Abstract][Full Text] [Related]
18. Flexible dosing of adjunctive zonisamide in the treatment of adult partial-onset seizures: a non-comparative, open-label study (ZEUS).
Dupont S; Striano S; Trinka E; Springub J; Giallonardo AT; Smith P; Ellis S; Yeates A; Baker G
Acta Neurol Scand; 2010 Mar; 121(3):141-8. PubMed ID: 20047564
[TBL] [Abstract][Full Text] [Related]
19. Zonisamide monotherapy for epilepsy in children and young adults.
Wilfong AA
Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764
[TBL] [Abstract][Full Text] [Related]
20. Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.
Ben-Menachem E; Gabbai AA; Hufnagel A; Maia J; Almeida L; Soares-da-Silva P
Epilepsy Res; 2010 May; 89(2-3):278-85. PubMed ID: 20299189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
